SC 13D/A
Beneficial Ownership Report
Mirum Pharmaceuticals, Inc. Filed Acc 0001193125-20-324514
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · JANUS HENDERSON GROUP Ltd. 8.5%
- 2026-08-13 SCHEDULE 13G/A · JANUS HENDERSON GROUP Ltd. 9.7%
- 2026-08-06 SCHEDULE 13G · FMR LLC 6.2%
- 2026-04-27 SCHEDULE 13G/A · BlackRock, Inc. 5.7%
- 2026-03-27 SCHEDULE 13G/A · The Vanguard Group 0%
- 2026-02-17 SCHEDULE 13G/A · JANUS HENDERSON GROUP PLC 11.8%
- 2026-02-13 SCHEDULE 13G/A · Eventide Asset Management, LLC 4.1%
- 2026-01-27 SCHEDULE 13D/A · Patrick J. Heron 6.8%
- 2025-12-05 SCHEDULE 13G/A · JANUS HENDERSON GROUP PLC 10.6%
- 2025-11-14 SCHEDULE 13G/A · JANUS HENDERSON GROUP PLC 10.0%
- 2025-11-14 SCHEDULE 13G/A · BVF PARTNERS L P/IL 3.0%
- 2019-09-10 SC 13G · Takeda Pharmaceutical Company Limited 8.1%
Loading d103425dsc13da.htm…